Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India
Natco Phrama launched the drug for the treatment of Hepatitis C Virus. It is a fixed combination of Sofosbuvir-Daclatasvir tablets under the brand name of Hepcinat Plus in India. The product is a generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg tablets used for the treatment of patients with chronic Hepatitis C virus infection, the company said in a filing to the BSE. Natco Phrama has launched Hepnicat Plus Tablet at the price of Rs. 17,500; it contains a bottle of 28 tablets.